Molecular Partners AG (MOLN)
4.17
+0.40
(+10.76%)
USD |
NASDAQ |
May 03, 15:51
Molecular Partners Total Assets (Quarterly): 236.15M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 236.15M |
| September 30, 2023 | 238.40M |
| June 30, 2023 | 256.31M |
| March 31, 2023 | 267.69M |
| December 31, 2022 | 282.87M |
| September 30, 2022 | 288.33M |
| June 30, 2022 | 313.61M |
| March 31, 2022 | 337.76M |
| December 31, 2021 | 188.89M |
| September 30, 2021 | 188.74M |
| June 30, 2021 | 224.74M |
| December 31, 2020 | 214.66M |
| June 30, 2020 | 77.10M |
| December 31, 2019 | 108.30M |
| June 30, 2019 | 138.08M |
| Date | Value |
|---|---|
| June 30, 2019 | 138.08M |
| December 31, 2018 | 157.59M |
| June 30, 2018 | 127.73M |
| June 30, 2018 | 127.73M |
| December 31, 2017 | 148.26M |
| June 30, 2017 | 168.54M |
| June 30, 2017 | 168.54M |
| December 31, 2016 | 180.92M |
| June 30, 2016 | 204.76M |
| June 30, 2016 | 204.76M |
| December 31, 2015 | 221.96M |
| June 30, 2015 | 208.91M |
| June 30, 2015 | 208.91M |
| December 31, 2014 | 196.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
77.10M
Minimum
Jun 2020
337.76M
Maximum
Mar 2022
218.73M
Average
230.45M
Median
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 2.270M |
| MoonLake Immunotherapeutics | 526.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.10M |
| Shareholders Equity (Quarterly) | 210.05M |
| Current Ratio | 13.35 |